dr. goldberg on sequencing following treatment with osimertinib in nsclc
Published 6 years ago • 232 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
1:16
dr. goldberg on options after developing resistance to osimertinib for nsclc
-
1:52
dr. goldberg discusses osimertinib in nsclc
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
2:50
sequencing with osimertinib in egfr-mutated nsclc
-
3:57
sequencing with osimertinib in egfr-positive nsclc
-
1:31
dr. oxnard on detecting resistance mechanisms after treatment with osimertinib
-
5:52
treatment of egfr nsclc after osimertinib
-
1:31
dr. gold on the future of osimertinib in lung cancer
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
8:55
global perspectives on use of osimertinib in egfr nsclc
-
3:17
osimertinib in egfr-positive nsclc with brain metastases
-
4:56
patient selection for osimertinib; thoughts on sequencing
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
9:49
osimertinib as frontline therapy for egfr-positive nsclc
-
2:21
treatment of egfr nsclc after progression
-
3:13
osimertinib responses after rociletinib treatment of t790m-positive nsclc
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies